{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T18:10:29Z","timestamp":1685383829910},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00105-009-1897-8","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T18:35:14Z","timestamp":1264012514000},"page":"69-80","source":"Crossref","is-referenced-by-count":3,"title":["Update: Dermatomyositis"],"prefix":"10.1007","volume":"61","author":[{"given":"B.","family":"Volc-Platzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,1,22]]},"reference":[{"key":"1897_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344\u2013347","journal-title":"N Engl J Med"},{"key":"1897_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(99)05157-0","volume":"355","author":"Callen","year":"2000","unstructured":"Callen JP (2000) Dermatomyositis. Lancet 355:53\u201357","journal-title":"Lancet"},{"key":"1897_CR3","first-page":"CD003643","volume":"3","author":"Choy","year":"2005","unstructured":"Choy EH, Hoogendijk JE, Lecky B, Winer JB (2005) Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 3:CD003643","journal-title":"Cochrane Database Syst Rev"},{"key":"1897_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/WNL.51.6_Suppl_5.S37","volume":"51","author":"Dalakas","year":"1998","unstructured":"Dalakas MC (1998) Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Neurology 51:37\u201345","journal-title":"Neurology"},{"key":"1897_CR5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s002560000238","volume":"29","author":"Garcia","year":"2000","unstructured":"Garcia J (2000) MRI in inflammatory myopathies. Skeletal Radiol 29:425\u2013438","journal-title":"Skeletal Radiol"},{"key":"1897_CR6","first-page":"373","volume":"14","author":"Gonzalez-Lopez","year":"1996","unstructured":"Gonzalez-Lopez L, Gamez-Nava JL, Sanchez L et al (1996) Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 14:373\u2013379","journal-title":"Clin Exp Rheumatol"},{"key":"1897_CR7","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/art.24547","volume":"60","author":"Gunawardena","year":"2009","unstructured":"Gunawardena H, Wedderburn LR, Chinoy H et al (2009) Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 60:1807\u20131814","journal-title":"Arthritis Rheum"},{"key":"1897_CR8","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.4049\/jimmunol.162.4.2315","volume":"162","author":"Hirakata","year":"1999","unstructured":"Hirakata M, Suwa A, Nagai S et al (1999) Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 162:2315\u20132320","journal-title":"J Immunol"},{"key":"1897_CR9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00002281-199711000-00007","volume":"9","author":"Hohlfeld","year":"1997","unstructured":"Hohlfeld R, Engel AG, Goebels N, Behrens L (1997) Cellular immune mechanisms in inflammatory myopathies. Curr Opin Rheumatol 9:520\u2013526","journal-title":"Curr Opin Rheumatol"},{"key":"1897_CR10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","volume":"94","author":"Joffe","year":"1993","unstructured":"Joffe MM, Love LA, Leff RL et al (1993) Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. Am J Med 94:379\u2013387","journal-title":"Am J Med"},{"key":"1897_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaad.2008.02.043","volume":"59","author":"Jorizzo","year":"2008","unstructured":"Jorizzo LJ, Jorizzo JI (2008) The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol 59:99\u2013112","journal-title":"J Am Acad Dermatol"},{"key":"1897_CR12","doi-asserted-by":"crossref","unstructured":"Love LA, Leff RL, Fraser DD et al (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogenous patient groups. Medicine (Baltimore) 70:360\u2013374","DOI":"10.1097\/00005792-199111000-00002"},{"key":"1897_CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(01)00478-6","volume":"185","author":"Mowzoon","year":"2001","unstructured":"Mowzoon N, Sussman A, Bradley WG (2001) Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis. J Neurol Sci 185:119\u2013122","journal-title":"J Neurol Sci"},{"key":"1897_CR14","first-page":"91","volume":"20","author":"Patheiger","year":"1991","unstructured":"Patheiger U, Hahn M, J\u00fcnger M et al (1991) Morphologische und funktionelle Ver\u00e4nderungen an Nagelfalzkapillaren bei Dermatomyositis. Phlebology 20:91\u201393","journal-title":"Phlebology"},{"key":"1897_CR15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-122-9-199505010-00010","volume":"122","author":"Plotz","year":"1995","unstructured":"Plotz PH, Rider LG, Targoff IN et al (1995) NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis and therapy. Ann Int Med 122:715\u2013724","journal-title":"Ann Int Med"},{"key":"1897_CR16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199202063260602","volume":"325","author":"Siguregeirsson","year":"1992","unstructured":"Siguregeirsson B, Lindel\u00f6f B, Edhag O, Allander E (1992) Risk of cancer with dermatomyositis and polymyositis. N Engl J Med 325:363\u2013367","journal-title":"N Engl J Med"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1897-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-009-1897-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-009-1897-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T17:56:27Z","timestamp":1685382987000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-009-1897-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["1897"],"URL":"https:\/\/doi.org\/10.1007\/s00105-009-1897-8","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}